Literature DB >> 26308634

The Neurological Compromised Spine Due to Ewing Sarcoma. What First: Surgery or Chemotherapy? Therapy, Survival, and Neurological Outcome of 15 Cases With Primary Ewing Sarcoma of the Vertebral Column.

Lida Mirzaei1, Suzanne E J Kaal, Hendrik W B Schreuder, Ronald H M A Bartels.   

Abstract

BACKGROUND: The vertebral column is an infrequent site of primary involvement in Ewing sarcoma. Yet when Ewing sarcoma is found in the spine, the urge for decompression is high because of the often symptomatic compression of neural structures. It is unclear in alleviating a neurological deficit whether chemotherapy is preferred over decompressive laminectomy.
OBJECTIVE: To underline, in this case series, the efficiency of initial chemotherapy before upfront surgery in the setting of high-grade spinal cord or cauda equina compression of primary Ewing sarcoma.
METHODS: Fifteen patients with Ewing sarcoma primarily located in the spine were treated at our institution between 1983 and 2015. Localization, neurological deficit expressed as Frankel grade, and outcome expressed as Rankin scale before and after initial chemotherapy, the recurrence rate, and overall survival were evaluated. The multidisciplinary approach of 1 case will be discussed in detail.
RESULTS: Nine patients (60%) were female. The age at presentation was 15.0 ± 5.5 years (range: 0.9-22.8 years). Ten patients (67%) were initially treated with chemotherapy, and 1 patient (7%) was treated primarily with radiotherapy followed by chemotherapy. The remaining 4 patients (27%) were initially treated with decompressive surgery. All patients treated primarily nonsurgically improved neurologically at follow-up, showing the importance of chemotherapy as an effective initial treatment option.
CONCLUSION: Adequate and quick decompression of neural structures with similar results can be achieved by chemotherapy and radiotherapy, avoiding the local spill of malignant cells.

Entities:  

Mesh:

Year:  2015        PMID: 26308634     DOI: 10.1227/NEU.0000000000000903

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Factors affecting survival outcomes of patients with non-metastatic Ewing's sarcoma family tumors in the spine: a retrospective analysis of 63 patients in a single center.

Authors:  Wei Wan; Yan Lou; Zhiqi Hu; Ting Wang; Jinsong Li; Yu Tang; Zhipeng Wu; Leqin Xu; Xinghai Yang; Dianwen Song; Jianru Xiao
Journal:  J Neurooncol       Date:  2016-10-17       Impact factor: 4.130

2.  Surgical management of an adult manifestation of Ewing sarcoma of the spine-a case report.

Authors:  Loay Shoubash; Stephan Nowak; Silke Vogelgesang; Henry W S Schroeder; Jan-Uwe Müller
Journal:  AME Case Rep       Date:  2018-06-29

3.  Impact of first-line treatment on outcomes of Ewing sarcoma of the spine.

Authors:  Jianjun Zhang; Yujing Huang; Jing Lu; Aina He; Yan Zhou; Haiyan Hu; Zan Shen; Yuanjue Sun; Yang Yao
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

4.  Primary malignant bone tumours of spine and pelvis in children.

Authors:  Ilkka J Helenius; Andreas H Krieg
Journal:  J Child Orthop       Date:  2021-08-20       Impact factor: 1.548

5.  Primary Ewing sarcoma/peripheral primitive neuroectodermal tumors in the cranial bone and mobile spine: what is the difference?

Authors:  Yu Wang; Hui Zhang; Jun Chen; Shi-Zhou Wu; Jie Tan; Qing-Yi Zhang; Bo-Quan Qin
Journal:  BMC Surg       Date:  2022-01-08       Impact factor: 2.102

6.  Effects of different treatments and other factors on the prognosis of patients with ewing sarcoma.

Authors:  Kunchi Hua; Yongcheng Hu
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.